Global Live Cell Imaging Market By Type (Consumables, Instruments, Software, and Services), By Application (Cell Biology, Stem Cell and Drug Discovery Developmental Biology, and Others), By Technology (Time-lapse Microscopy, High Content Screening, Fluorescence resonance energy transfer (FRET) and Others), By End User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

In 2022, the Global Live Cell Imaging Market was valued at USD 2.8 Billion and is expected to grow to USD 6.7 billion in 2032. Between 2023 and 2032, this market is estimated to register the highest CAGR of 9.4%.

The study of living cells using time-lapse microscopy is also known as live-cell imaging. Cell study was also conducted using real-time pictures from several efficient microscopes and screening systems. This advanced technology supports researchers worldwide to detect the processes in real-time and cell structures, offering a better understanding of the cell operations related to the photograph provided by imaging fixed cells.

The growing concern about cancer is a significant factor in the increasing demand for advanced technology. The government is taking initiatives to invest in cell-based research.

Live-cell imaging has a wide area of application and can be used to understand cellular structures and active processes. It is operated to investigate cellular integrity, enzyme activity, exocytosis, protein trafficking, molecule localization, endocytosis, and others. The method is used to give path molecules in living animals.

The pharmaceutical sector increasingly uses live-cell imaging to reveal innovative medicines in development and research. Live-cell imaging is also used in high-content screening. However, the cost of implementing devices is extremely high, hindering this market’s growth. The technique necessitates a highly qualified individual’s study and comprehension of cell activities.

The lack of experienced specialists also restricts the growth of the Market. However, increasing funding for development programs and training this component has a long-term effect. The pharmaceutical sector widely uses implanting devices. It is expected to increase in demand in the coming future.

Key Takeaways

• In 2022, the live cell imaging market was worth US$ 2.8 Billion.
• The market is projected to reach US$ 6.7 Billion by 2032.
• The estimated CAGR between 2023 and 2032 is 9.4%.
• The Instruments segment holds the largest market share in Live Cell Imaging.
• The Consumables segment is expected to have the highest CAGR in the coming years.
• Cell Biology is the dominant application in Live Cell Imaging.
• The Fluorescence Resonance Energy Transfer (FRET) technology segment has the largest market share.
• Pharmaceutical and Biotechnological Companies are the leading end-users of Live Cell Imaging.
• The North America region holds the largest market share in Live Cell Imaging.
• The Asia-Pacific region is expected to experience the fastest growth in the market.
• Danaher Corporation, Nikon Corporation, and Olympus Corporation are some of the major players in the market.

Type Analysis

The Instruments Segment Held the Largest Shares In the Live Cell Imaging Market

Based on type, the market is segmented into Instruments, Consumables, and Software. Instruments dominated the market, accounting for the largest market share. This is due to the increased use of instruments for analyzing, recording, and gaining insight related to cell operations. The instruments segment covers cell analyzers, image-capturing systems, and standalone systems.

Technological advances, including the creation of new microscopes, are driving the adoption of instruments. The consumable segment will see the greatest CAGR in the next few years. This is mainly because of the increased demand for consumables in live-cell imaging, resulting in repeated purchases.

Application Analysis

Cell Biology Dominates the Product Segment in the Live Cell Imaging Market

Based on Application, The market is segmented into Cell Biology, Developmental Biology, Stem Cell and Drug Discovery, and Others. Cell biology has emerged as a major segment due to significant growth in research and studies on molecular interaction networks. Live-cell imaging is essential for cell biologists and cell-based researchers. It allows them to understand the elements of cellular structures, as well as the interaction with the tissues.

This technology provides superior clarity and spatial heterogeneity, which is why it is being adopted in cell biology research. Live cell imaging has become popular due to high-content screening techniques used in drug discovery. There is also a growing demand for faster diagnostic facilities and funding from the government for cell-based research. Live-cell imaging can be used to detect cell-based assays or high-content screening techniques in drug discovery. It helps identify multiple measures of cell biology, including sub-cellular compartments and multicellular structures.

Technology Analysis

The Fluorescence Resonance Energy Transfer Segment Held the Largest Share In Technology Market Segment

Based on Technology, the live cell imaging market is segmented into High Content Screening,  Fluorescence resonance energy transfer segment, time-lapse microscopy, and Others. The Fluorescence resonance Energy Transfer segment accounted for the largest percentage due to its many advantages in determining the spatial proximity of the protein levels.

This technology has become increasingly popular due to the increasing use of genetic peptides. The “Studying SARS-CoV-2 using Fluorescence Microscopy” research revealed that a fluorescent microscope could be used to examine molecular biology and other viruses. This market will grow as more live cell imaging equipment becomes available to study molecular biology.

End-User Analysis

Pharmaceutical and Biotechnological Companies Dominate the Market

Based on End-User, the market is segmented into Biotechnology  & Pharmaceutical Companies, Research & Academic Institutes, and Others. Due to their significant investments in research and development dedicated to the development of new drugs, the Pharmaceutical & Biotechnology Companies dominated this end-user market. Live-cell imaging technology has also been able to benefit from companies’ shifts in interest toward the development of personalized medicine.

Key Market Segments

Based on type

• Consumables
• Instruments
• Software
• Services

Based on Application

• Cell Biology
• Stem Cell and Drug Discovery
• Developmental Biology
• Other Applications

Based on Technology

• Time-lapse Microscopy
• Fluorescence resonance energy transfer (FRET)
• High Content Screening (HCS)
• Fluorescence Recovery After Photobleaching

Based on End-User

• Academic and Research Institutes
• Pharmaceutical and Biotechnological Companies
• Contract Research Organisations

Drivers

Growing Adaption of High Content Screening Techniques in Drug Discovery

The live cell imaging market is driven by the adoption of high-content screening methods, government investment for cell-based research, and increasing incidences of cancer. The market’s growth is impeded by a lack of skilled professionals and the high cost of high-content screening systems.

Market players have growth potential due to the adoption of comfortable screening methods for crucial screening as well as live cell imaging for personalized medicine. These chronic diseases are increasing, which will drive the market for diagnostic services that can provide a reliable and fast diagnosis.

Restraints

The High Cost of High Content Screening Systems

It can be challenging to run live cell imaging experiments efficiently. The success or failure of experiments depends on the condition in which the cells are kept under the microscope. An essential part of experiments is to keep live cells on slides. Temperature plays a crucial role in maintaining cell viability within a culture. Cell viability and cell environment are dependent on several requirements. Therefore, the chances of live cell imaging experiments being unsuccessful are very high.

High-end content screen instruments are equipped with advanced functionalities & features and are available at a premium price. Because of their limited budgets, Academic Research Laboratories are unable to afford these expensive instruments. Many pharmaceutical companies are concerned about the high price of these instruments because they require high-quality screening systems for their R&D activities.

Opportunity

Untapped Potential of Emerging Market

Due to the growing healthcare industry in emerging countries like Brazil, India, South Africa, and China, the global anatomic pathology market is also increasing. Oncology drug trials use anatomic pathology products to analyze quantitative data, identify structures and pharmacodynamics markers and understand drug mechanisms.

It separates the subjects based on their tissue response to drugs. Tissue diagnostics make it possible to conduct efficient retrospective and prospective studies. They also reduce the time and cost of the process. These economies have increased their investment in healthcare infrastructure and facilities. The rising market for anatomic pathology products is expected to provide growth opportunities due to the large number of their applications in the healthcare industry.

Trends

Increase in Advancement and Newer Imaging Techniques

In developed countries, the demand for regenerative medicine is increasing. Investments in cell and gene therapy have risen dramatically in recent years. The public and private sectors are leading in funding gene therapy and cell-based research. Many government agencies and private companies have recently started funding biotech start-ups.

Research institutes to invest in cell, and gene therapy product R&D. The combination of scientific research and technological advancements in imaging and labeling technology allows for live cell imaging. Scientists can use live cell imaging by combining technological advances with biological interests.

The exciting advancements in probe development have allowed for a wide range of nucleic acids, proteins, glycons, cholesterols, lipids, and metabolites to be labeled. Software that allows for better analysis of label-free images, enabling many recent advances in microscopic technology.

Regional Analysis

The North America Region Holds the Largest Market Share and is Expected to Follow the Same Trend over the Forecast Period

Based on Regional Analysis, the Global Live-Cell Imaging Market can be divided into North America, Europe, Asia Pacific, and the Rest of the World. North America is the largest region in the global Live-Cell Imaging Market. This is due to its rapid adoption of advanced technology and favorable drug development regulations.

It also has top biotechnology companies and pharmaceutical companies. The region also receives growth funding for various biological research projects. The fastest growth rate is expected in Asia-Pacific, mainly because of significant government investment in research and development and the large number of patients who demand personalized and efficient medicines.

This growth could be due to the increasing incidence of cancers and other infectious diseases, rising demand for stem cell research studies, rising R&D expenses, increased utility biomarkers for diagnostic purposes, and growing awareness for cell and gene therapies.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Developing market players are focused on various strategic policies to improve their own productions in foreign marketplaces. Various live cell imaging market industries are focused on expanding their R&D facilities and present operations.

However, industries in the live cell imaging market are developing new products, mergers, and portfolio development strategies through investments, and acquisitions. In addition, many key players are now focusing on different marketing strategies, such as increasing awareness about natural components, which helps to boost the target products’ growth.

With the presence of many local and regional players, the market for Live Cell Imaging devices is fragmented. Market players are subject to intense competition from top market players, particularly those with strong brand recognition and high distribution networks. Companies have gained various expansion strategies, such as partnerships and product launches, to stay on top of the market.

Below are some of the most prominent Global Live Cell Imaging industry players.

Market Key Players

• Danaher Corporation
• Nikon Corporation
• Olympus Corporation
• PerkinElmer, Inc.
• E. Healthcare
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Sartorius AG
• Oxford Instruments
• BioTech Instruments
• Bio-Rad Laboratories
• Etaluma Inc.
• Other Key Players

Recent Developments

• In April 2022: CytoSMART Technologies introduced the Omni FL, a live-cell imaging system incorporating red and green fluorescence channels in its Omni product line.
• In March 2022: Axion BioSystems is a leader in life sciences devices and focuses on advanced live-cell analysis systems. It has announced the investment of CytoSMART Technologies from the Netherlands. This company is a pioneer in live cell imaging analysis.

Report Scope